180 related articles for article (PubMed ID: 19879919)
21. Caspase-mediated p65 cleavage promotes TRAIL-induced apoptosis.
Kim HS; Chang I; Kim JY; Choi KH; Lee MS
Cancer Res; 2005 Jul; 65(14):6111-9. PubMed ID: 16024612
[TBL] [Abstract][Full Text] [Related]
22. Anaplastic thyroid cancer: a comprehensive review of novel therapy.
Kojic SL; Strugnell SS; Wiseman SM
Expert Rev Anticancer Ther; 2011 Mar; 11(3):387-402. PubMed ID: 21417853
[TBL] [Abstract][Full Text] [Related]
23. Oncogenic and anti-apoptotic activity of NF-kappa B in human thyroid carcinomas.
Pacifico F; Mauro C; Barone C; Crescenzi E; Mellone S; Monaco M; Chiappetta G; Terrazzano G; Liguoro D; Vito P; Consiglio E; Formisano S; Leonardi A
J Biol Chem; 2004 Dec; 279(52):54610-9. PubMed ID: 15475567
[TBL] [Abstract][Full Text] [Related]
24. Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB.
Kasof GM; Lu JJ; Liu D; Speer B; Mongan KN; Gomes BC; Lorenzi MV
Oncogene; 2001 Nov; 20(55):7965-75. PubMed ID: 11753679
[TBL] [Abstract][Full Text] [Related]
25. Molecular pathogenesis of follicular cell derived thyroid cancers.
Parameswaran R; Brooks S; Sadler GP
Int J Surg; 2010; 8(3):186-93. PubMed ID: 20097316
[TBL] [Abstract][Full Text] [Related]
26. Targeting the RET pathway in thyroid cancer.
Wells SA; Santoro M
Clin Cancer Res; 2009 Dec; 15(23):7119-23. PubMed ID: 19934298
[TBL] [Abstract][Full Text] [Related]
27. Nuclear factor-kappaB in development, prevention, and therapy of cancer.
Van Waes C
Clin Cancer Res; 2007 Feb; 13(4):1076-82. PubMed ID: 17317814
[TBL] [Abstract][Full Text] [Related]
28. Nuclear factor-kappaB activation: from bench to bedside.
Sethi G; Sung B; Aggarwal BB
Exp Biol Med (Maywood); 2008 Jan; 233(1):21-31. PubMed ID: 18156302
[TBL] [Abstract][Full Text] [Related]
29. An update on molecular biology of thyroid cancers.
Omur O; Baran Y
Crit Rev Oncol Hematol; 2014 Jun; 90(3):233-52. PubMed ID: 24405857
[TBL] [Abstract][Full Text] [Related]
30. The nuclear factor kappa-B signaling pathway as a therapeutic target against thyroid cancers.
Li X; Abdel-Mageed AB; Mondal D; Kandil E
Thyroid; 2013 Feb; 23(2):209-18. PubMed ID: 23273524
[TBL] [Abstract][Full Text] [Related]
31. FKBP51 and the NF-κB regulatory pathway in cancer.
Romano S; Mallardo M; Romano MF
Curr Opin Pharmacol; 2011 Aug; 11(4):288-93. PubMed ID: 21565553
[TBL] [Abstract][Full Text] [Related]
32. Nuclear factor-kB in thyroid carcinogenesis and progression: a novel therapeutic target for advanced thyroid cancer.
Namba H; Saenko V; Yamashita S
Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):843-51. PubMed ID: 17891249
[TBL] [Abstract][Full Text] [Related]
33. RbAp48 is a target of nuclear factor-kappaB activity in thyroid cancer.
Pacifico F; Paolillo M; Chiappetta G; Crescenzi E; Arena S; Scaloni A; Monaco M; Vascotto C; Tell G; Formisano S; Leonardi A
J Clin Endocrinol Metab; 2007 Apr; 92(4):1458-66. PubMed ID: 17244783
[TBL] [Abstract][Full Text] [Related]
34. LDOC1 is differentially expressed in thyroid cancer and display tumor-suppressive function in papillary thyroid carcinoma.
Zhao S; Zhao Y; Wang Q; Li Z; Ma X; Wu L; Li W; Du M; Ji H; Qin G
Cell Biol Int; 2020 Apr; 44(4):985-997. PubMed ID: 31889386
[TBL] [Abstract][Full Text] [Related]
35. Autophagy and thyroid carcinogenesis: genetic and epigenetic links.
Morani F; Titone R; Pagano L; Galetto A; Alabiso O; Aimaretti G; Isidoro C
Endocr Relat Cancer; 2014 Feb; 21(1):R13-29. PubMed ID: 24163390
[TBL] [Abstract][Full Text] [Related]
36. Activation of the IGF Axis in Thyroid Cancer: Implications for Tumorigenesis and Treatment.
Manzella L; Massimino M; Stella S; Tirrò E; Pennisi MS; Martorana F; Motta G; Vitale SR; Puma A; Romano C; Di Gregorio S; Russo M; Malandrino P; Vigneri P
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31269742
[TBL] [Abstract][Full Text] [Related]
37. Modeling thyroid cancer in the mouse.
Zhu XG; Cheng SY
Horm Metab Res; 2009 Jun; 41(6):488-99. PubMed ID: 19358084
[TBL] [Abstract][Full Text] [Related]
38. Multi-targeted approach in the treatment of thyroid cancer.
Zarebczan B; Chen H
Minerva Chir; 2010 Feb; 65(1):59-69. PubMed ID: 20212418
[TBL] [Abstract][Full Text] [Related]
39. Clinical and Translational Challenges in Thyroid Cancer.
Hernando J; Ros J; Arroyo A; Capdevila J
Curr Med Chem; 2020; 27(29):4806-4822. PubMed ID: 32056516
[TBL] [Abstract][Full Text] [Related]
40. Novel Therapeutics in Radioactive Iodine-Resistant Thyroid Cancer.
Fullmer T; Cabanillas ME; Zafereo M
Front Endocrinol (Lausanne); 2021; 12():720723. PubMed ID: 34335481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
